メインコンテンツにスキップ
検索

薬事規制

登録

最新のリソース

注目コンテンツ

Upcoming regulatory webinars

Latest regulatory blogs

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

RAPS Convergence 2026

September 15 - 17, 2026 – Charlotte Convention Center, Charlotte, North Carolina – Booth 1019
展示会・学会

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

September 16 - 18, 2026
展示会・学会

2026 ACCP Annual Meeting

September 27 - 29, 2026 – Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD

All regulatory resources

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

The five drug development questions that bring sponsors to pharmacometrics

Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Pharmacometrics, Blog

Model-Based Meta-Analysis (MBMA): Real-World Examples

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - MBMA, Fact Sheet

A model-informed approach to radioligand therapy dosing under Project Optimus

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Blog

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Model Informed Drug Development, On-Demand Webinar

基本的なバリデーションの、その先へ：Pinnacle 21 Enterpriseで、申請対応可能なデータセットを実現

CDISC, Certara Products - Pinnacle 21, Fact Sheet

EANM 2026

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Webinar

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

Certara Services, Drug Development, Webinar

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Conference

Integrated mechanistic modeling approaches in oncology drug development

Biologics, Certara Products - Certara IQ, Certara Products - Simcyp, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Webinar
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software